Intestinal Mucosal Barrier Is Regulated by Intestinal Tract Neuro-Immune Interplay

Inflammatory bowel disease, irritable bowel syndrome and severe central nervous system injury can lead to intestinal mucosal barrier damage, which can cause endotoxin/enterobacteria translocation to induce infection and is closely related to the progression of metabolic diseases, cardiovascular and...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology Vol. 12; p. 659716
Main Authors: You, Xin-yu, Zhang, Han-yu, Han, Xu, Wang, Fang, Zhuang, Peng-wei, Zhang, Yan-jun
Format: Journal Article
Language:English
Published: Frontiers Media S.A 31-05-2021
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Inflammatory bowel disease, irritable bowel syndrome and severe central nervous system injury can lead to intestinal mucosal barrier damage, which can cause endotoxin/enterobacteria translocation to induce infection and is closely related to the progression of metabolic diseases, cardiovascular and cerebrovascular diseases, tumors and other diseases. Hence, repairing the intestinal barrier represents a potential therapeutic target for many diseases. Enteral afferent nerves, efferent nerves and the intrinsic enteric nervous system (ENS) play key roles in regulating intestinal physiological homeostasis and coping with acute stress. Furthermore, innervation actively regulates immunity and induces inherent and adaptive immune responses through complex processes, such as secreting neurotransmitters or hormones and regulating their corresponding receptors. In addition, intestinal microorganisms and their metabolites play a regulatory role in the intestinal mucosal barrier. This paper primarily discusses the interactions between norepinephrine and β-adrenergic receptors, cholinergic anti-inflammatory pathways, nociceptive receptors, complex ENS networks, gut microbes and various immune cells with their secreted cytokines to summarize the key roles in regulating intestinal inflammation and improving mucosal barrier function.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
This article was submitted to Gastrointestinal and Hepatic Pharmacology, a section of the journal Frontiers in Pharmacology
Min Jiang, Nankai University, China
Edited by: Tao Xu, Anhui Medical University, China
Reviewed by: Jianye Yuan, Longhua Hospital Shanghai University of Traditional Chinese Medicine, China
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2021.659716